Pancreatic Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Pancreatic Cancer, including details on symptoms, causes, treatment, information.

Volume 3 (2006), Issue 5 (May)

1. Dual-color imaging of nascent blood vessels vascularizing pancreatic cancer in an orthotopic model demonstrates antiangiogenesis efficacy of gemcitabine.
   J Surg Res, 132(2): 164-9. [Abstract] [Full-text]
2. High-level Skp2 expression in pancreatic ductal adenocarcinoma: correlation with the extent of lymph node metastasis, higher histological grade, and poorer patient outcome.
   Pancreas, 32(4): 376-81. [Abstract] [Full-text]
3. The expression of adhesion molecules and the influence of inflammatory cytokines on the adhesion of human pancreatic carcinoma cells to mesothelial monolayers.
   Pancreas, 32(4): 396-402. [Abstract] [Full-text]
4. Aberrant methylation of secreted apoptosis-related protein 2 (SARP2) in pure pancreatic juice in diagnosis of pancreatic neoplasms.
   Pancreas, 32(4): 382-9. [Abstract] [Full-text]
5. Phase I study of the humanised anti-EGFR monoclonal antibody matuzumab (EMD 72000) combined with gemcitabine in advanced pancreatic cancer.
   Br J Cancer, 94(9): 1293-9. [Abstract] [Full-text]
6. The alpha2beta1 integrin mediates the malignant phenotype on type I collagen in pancreatic cancer cell lines.
   Br J Cancer, 94(9): 1311-9. [Abstract] [Full-text]
7. Cyclophilin A is overexpressed in human pancreatic cancer cells and stimulates cell proliferation through CD147.
   Cancer, 106(10): 2284-94. [Abstract] [Full-text]
8. Temporary diabetes mellitus secondary to a primary pancreatic Burkitt lymphoma.
   Pediatr Blood Cancer, 47(1): 94-6. [Abstract] [Full-text]
9. Oncogenic K-Ras down-regulates Rac1 and RhoA activity and enhances migration and invasion of pancreatic carcinoma cells through activation of p38.
   Cell Signal, 18(8): 1156-68. [Abstract] [Full-text]
10. Regulation of vascular endothelial growth factor receptor-2 expression in pancreatic cancer cells by Sp proteins.
    Biochem Biophys Res Commun, 345(1): 292-301. [Abstract] [Full-text]
11. A phase II study of irinotecan with 5-fluorouracil and leucovorin in patients with pretreated gastroenteropancreatic well-differentiated endocrine carcinomas.
    Oncology, 70(2): 134-40. [Abstract] [Full-text]
12. Inferior branch-preserving superior head resection of the pancreas with gastric wall-covering method for intraductal papillary mucinous adenoma.
    Am J Surg, 191(6): 823-6. [Abstract] [Full-text]
13. Clinical usefulness of 18-fluorodeoxyglucose positron emission tomography in the management of patients with nonpancreatic periampullary neoplasms.
    Am J Surg, 191(6): 743-8. [Abstract] [Full-text]
14. Toward zero pancreatic fistula after pancreaticoduodenectomy with pancreaticogastrostomy.
    Am J Surg, 191(6): 726-32; discussion 733-4. [Abstract] [Full-text]
15. Increased integrity of free circulating DNA in sera of patients with colorectal or periampullary cancer: direct quantitative PCR for ALU repeats.
    Clin Chem, 52(6): 1062-9. [Abstract] [Full-text]
16. Correlation of patient-derived utility values and quality of life after pancreaticoduodenectomy for pancreatic cancer.
    J Am Coll Surg, 202(6): 906-11. [Abstract] [Full-text]
17. 50-year appraisal of gastrinoma: recommendations for staging and treatment.
    J Am Coll Surg, 202(6): 897-905. [Abstract] [Full-text]

© 2004-2010 Pancreatic Cancer Research Today. All Rights Reserved.